Enzymit

📍 Ness-Ziona, Israel🗓 Founded 2020👥 23 employees💰 Last funded May 2021
Enzymit is setting a new paradigm for bioproduction through the design and creation of novel enzymes that streamline production processes, reduce costs and promote sustainability. Through cell-free, synthetic biology bioproduction, we aim to make faster, simpler, and more cost-effective than fermentation-based methods, meeting the demands of a constantly evolving world. Established in 2020 by experts in computational science, Enzymit uses deep learning algorithms and high-throughput testing methods to develop novel enzymes for various applications such as fine chemical manufacturing, foodtech, health, biodefense and more. Our team collaborates with global manufacturers across multiple industries, driving both expansion and market impact.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Enzymit?
Enzymit has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Enzymit last raise funding?
The most recent investment in Enzymit recorded on gritt.io was in May 2021.
When was Enzymit founded?
Enzymit was founded in 2020.
What industry is Enzymit in?
Enzymit operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Enzymit based?
Enzymit is headquartered in Ness-Ziona, Israel.